138 related articles for article (PubMed ID: 20638818)
1. Prospective randomized trial of short-term neoadjuvant chemotherapy for advanced gastric cancer.
Imano M; Itoh T; Satou T; Sogo Y; Hirai H; Kato H; Yasuda A; Peng YF; Shinkai M; Yasuda T; Imamoto H; Okuno K; Shiozaki H; Ohyanagi H
Eur J Surg Oncol; 2010 Oct; 36(10):963-8. PubMed ID: 20638818
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer.
Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A
Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy for locally advanced gastric cancer].
Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E
Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621
[TBL] [Abstract][Full Text] [Related]
5. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy with CDDP and 5-fluorouracil for gastric cancer with serosal invasion.
Takiguchi N; Nunomura M; Koda K; Oda K; Suzuki H; Miyazaki M
Oncol Rep; 2003; 10(2):433-8. PubMed ID: 12579285
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
[TBL] [Abstract][Full Text] [Related]
8. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
Yabusaki H; Nashimoto A; Tanaka O
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
[TBL] [Abstract][Full Text] [Related]
10. [Seven patients with stage IVb advanced gastric cancer who were treated with preoperative chemotherapy].
Yamanaka N; Morisaki T; Nakamura K; Ogawa T; Uchiyama A; Noshiro H; Kuroiwa T; Chijiiwa K; Tanaka M
Gan To Kagaku Ryoho; 2000 Mar; 27(3):459-63. PubMed ID: 10740641
[TBL] [Abstract][Full Text] [Related]
11. [Three successful case reports of advanced gastric cancer with chemotherapy].
Yamamoto M; Niinobu T; Taniguchi H; Kotobuki T; Fukunaga K; Kawai M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1689-92. PubMed ID: 15553684
[TBL] [Abstract][Full Text] [Related]
12. [Neoadjuvant chemotherapy for advanced gastric cancer using FLEP therapy].
Mochizuki F; Fujii M; Kasakura Y; Kochi M; Imai S; Eguchi T; Tsuneda Y; Kanamori N; Kaiga T; Kobayashi M
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1812-5. PubMed ID: 11086418
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and apoptosis-associated gene products related to the response to neoadjuvant chemotherapy for gastric cancer.
Satomi D; Takiguchi N; Koda K; Oda K; Suzuki H; Yasutomi J; Ishikura H; Miyazaki M
Int J Oncol; 2002 Jun; 20(6):1167-71. PubMed ID: 12011994
[TBL] [Abstract][Full Text] [Related]
14. [Pathological evaluation of neoadjuvant chemotherapy with low-dose FP therapy for advanced gastric cancer].
Takano S; Oda K; Koda K; Seike K; Takiguchi N; Miyazaki M
Gan To Kagaku Ryoho; 2007 Apr; 34(4):555-8. PubMed ID: 17431341
[TBL] [Abstract][Full Text] [Related]
15. A combination chemotherapy of 5-fluorouracil and cisplatin against advanced gastric cancer.
Imada T; Sairenji M; Suda T; Yamamoto Y; Amano T; Motohashi H
Hepatogastroenterology; 1999; 46(25):594-600. PubMed ID: 10228867
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant chemotherapy for advanced gastric cancer with para-aortic lymph node metastasis].
Uehara S; Murabayashi K; Kusta T; Takahashi K; Ogawa T; Onishi H; Saegusa S; Noda N; Okanami Y; Nakamura I
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1413-8. PubMed ID: 11681249
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
18. [A patient with advanced gastric cancer surviving for more than 5 years after neoadjuvant chemotherapy and curative resection].
Hirota M; Kimura J; Eguchi T; Kato K; Kobayashi H; Kanazumi N; Suzuki Y; Ishii M
Gan To Kagaku Ryoho; 2002 Jan; 29(1):125-9. PubMed ID: 11816468
[TBL] [Abstract][Full Text] [Related]
19. [Curative resection of advanced gastric cancer responding to preoperative chemotherapy--a case report].
Kobayashi M; Kasakura Y; Fujii M; Mochizuki F; Kochi M; Eguchi T; Imai S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):527-30. PubMed ID: 11329789
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
